Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

CUSIP: 74365U107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
54,102,569
Total 13F shares
5,927,042
Share change
-567,926
Total reported value
$18,391,293
Price per share
$2.93
Number of holders
31
Value change
-$2,063,463
Number of buys
9
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 74365U107?
CUSIP 74365U107 identifies TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q2 2022

As of 30 Jun 2022, Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,927,042 shares. The largest 10 holders included Opaleye Management Inc., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Ikarian Capital, LLC, CITADEL ADVISORS LLC, BOXER CAPITAL, LLC, BAKER BROS. ADVISORS LP, DLD Asset Management, LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.